In Israel, Evogene may be looking to trade in the North American markets after spinning off from Compugen Ltd in 2007. They are currently looking for a market where the “expertise of the agricultural sector high,” said Ofer Haviv, CEO. “We are currently in the Tel Aviv 100 Index, but that’s not enough.” The company has a market value of $200 million, with a .29 percent weight in the capitalization-weighted index of 100 stocks traded in Tel Aviv.
More on the story.
